Tag:#European cannabis

Leading German Pharma Company Launches Medical Cannabis Range Into Fast-Growing Domestic Market

ONE of Germany’s largest pharmaceutical firms has entered the medical cannabis space with the launch of a two flower products - and six more...

World’s Largest Cannabis Deal Sees UK Firm GW Pharma Bought For $7.2bn

IRISH firm Jazz Pharmaceuticals has agreed to purchase UK medical cannabis trailblazer GW Pharmaceuticals for $7.2bn. The deal will be the biggest ever transaction in...

Restoration Of Sanity To European CBD Market Boosts German Cannabis Firm’s $4.8m Fundraise

GERMAN cannabis firm Sanity kept a clear head to secure $4.8m of new investment - despite the European Commission’s recent narcotic CBD implosion. Its latest...

Markets: Joe Biden Delivers A Boost To America’s Cannabis Industry – With Europe Set To Benefit

CANNABIS stocks are expected to maintain their post-Election surge this week with Joe Biden now confirmed as the 46th President of the United States...

New European Ecosystem Highlights Emerging Opportunities For Cannabis Entrepreneurs

IN spite of its delayed arrival Europe has a first-class opportunity to become a world-leader in the emerging global cannabis industry. This is one of...

Cannabis Industry Changing As Covid-19 Shifts Global Focus To National Health

THE local corner shop has never been so busy, with stock squeezed into every conceivable corner a former struggling business has been transformed and...

Latest news

European Cannabis Stocks Review: Celadon Shares Spike 150% On Licence Update, OCT Continues Recovery, & Creso Pharma Censured By ASX

Celadon Pharmaceuticals  Celadon Pharmaceuticals stock has skyrocketed by more than 150% this week following the announcement that its current Home...
- Advertisement -spot_imgspot_img

Benefits of F1 Cannabis Hybrids from Royal Queen Seeds

F1 hybrids have revolutionised the way we grow and use plants. Now, F1 cannabis seeds are bringing growers, smokers,...

Celadon Pharmaceuticals Announces Home Office Approval Of Licence For Commercial Sale Of GMP Cannabis

PRESS RELEASE FURTHER to the announcement dated 16 January 2023, Celadon Pharmaceuticals Plc (AIM: CEL), a UK-based pharmaceutical company focused on...

Must read